NR1H4 and metabolic dysfunction-associated steatohepatitis: Farnesoid X receptor (FXR) plays a pivotal role in the pathogenesis of MASH by modulating several critical pathways, including bile acid synthesis and enterohepatic circulation, lipid and glucose metabolism, inflammation, fibrosis, gut barrier integrity, and intestinal microbiota [112].